Modification of a Tumor Antigen Determinant To Improve Peptide/MHC Stability Is Associated with Increased Immunogenicity and Cross-Priming a Larger Fraction of CD8+T Cells-Reference-Cited by-同舟云学术

Modification of a Tumor Antigen Determinant To Improve Peptide/MHC Stability Is Associated with Increased Immunogenicity and Cross-Priming a Larger Fraction of CD8+T Cells

Published:2012-11-21 Issue:12 Volume:189 Page:5549-5560
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Watson Alan M.,Mylin Lawrence M.,Thompson Megan M.,Schell Todd D.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference66 articles.

1. Accumulation of CD8+T Cells in Advanced-Stage Tumors and Delay of Disease Progression following Secondary Immunization against an Immunorecessive Epitope

2. Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors

3. Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes

4. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection.;van der Most;J. Immunol.,1996

5. Memory CD8+T Cells Specific for a Single Immunodominant or Subdominant Determinant Induced by Peptide-Dendritic Cell Immunization Protect from an Acute Lethal Viral Disease

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T-Cell Responses to Immunodominant Listeria Epitopes Limit Vaccine-Directed Responses to the Colorectal Cancer Antigen, Guanylyl Cyclase C;Frontiers in Immunology;2022-03-09

2. Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology;OncoImmunology;2020-01-01

3. Glial TLR2‐driven innate immune responses and CD8 + T cell activation against brain tumor;Glia;2019-02-05

4. Evolving Approaches in the Identification of Allograft-Reactive T and B Cells in Mice and Humans;Transplantation;2017-11

5. Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics;OncoImmunology;2017-10-04